Ligands binding the complex of urokinase-type plasminogen activator(uPA) and its receptor(uPAR) that inhibit downstream upar interactions: identification and use in diagnosis or therapy
Antibodies or other ligands specific for the binary uPA-uPAR complexes, for ternary complexes comprising uPA-uPAR and for complexes of uPAR and proteins other than uPA such as integrins inhibit the interaction of uPA and uPAR with additional molecules with which the complexed interact. Such antibodies or other ligands are used in diagnostic and therapeutic methods, particularly against cancer.